Bristol-Myers Squibb (NYSE: BMY) is a global biopharmaceutical company committed to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Phone: 212-546-4000
345 Park Avenue
New York, 10154
New York, United States
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2018-07-19 | IFM Tre | Series A | $31M | Abingworth, Atlas Venture, and IFM Therapeutics |
| 2018-01-04 | Enterome | Series D | $38.61M | Lundbeckfond Ventures, Nestle Health Science, Omnes Capital, Principia SGR, and Seventure Partners |
| 2017-12-21 | TARIS Biomedical | Series B | $25M | Flagship Pioneering, Norma Investments, Polaris Partners, RA Capital Management, and Yonghua Capital |
| 2017-10-30 | Personal Genome Diagnostics | Series B | $75M | Co-win Healthcare Fund, Helsinn Investment Fund, Inova Strategic Investments, Maryland Venture Fund, New Enterprise Associates, and Windham Venture Partners |
| 2017-08-03 | IFM Therapeutics | Acquired |
